Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Air Pollutants | 33 | 2011 | 2889 | 2.030 |
Why?
|
Particulate Matter | 27 | 2011 | 2597 | 1.850 |
Why?
|
Germany | 39 | 2012 | 872 | 1.220 |
Why?
|
Environmental Monitoring | 17 | 2011 | 1460 | 1.180 |
Why?
|
Air Pollution | 15 | 2011 | 2351 | 1.110 |
Why?
|
Particle Size | 30 | 2011 | 1649 | 1.090 |
Why?
|
Fibrinogen | 9 | 2011 | 888 | 1.060 |
Why?
|
Inhalation Exposure | 9 | 2011 | 432 | 0.940 |
Why?
|
Myocardial Infarction | 24 | 2011 | 11476 | 0.850 |
Why?
|
Urban Health | 6 | 2011 | 532 | 0.740 |
Why?
|
Vehicle Emissions | 6 | 2011 | 655 | 0.650 |
Why?
|
Respiratory Tract Diseases | 6 | 2011 | 748 | 0.640 |
Why?
|
C-Reactive Protein | 13 | 2010 | 3821 | 0.640 |
Why?
|
Environmental Exposure | 13 | 2011 | 4479 | 0.570 |
Why?
|
Mortality | 6 | 2011 | 2896 | 0.530 |
Why?
|
Polymorphism, Single Nucleotide | 30 | 2012 | 15920 | 0.510 |
Why?
|
Heart Rate | 9 | 2011 | 4197 | 0.500 |
Why?
|
Interleukin-6 | 7 | 2010 | 3210 | 0.480 |
Why?
|
Arrhythmias, Cardiac | 4 | 2012 | 2247 | 0.400 |
Why?
|
Survivors | 6 | 2010 | 2369 | 0.360 |
Why?
|
Myocardial Ischemia | 5 | 2011 | 2133 | 0.360 |
Why?
|
Seasons | 10 | 2011 | 1518 | 0.350 |
Why?
|
Cardiovascular Diseases | 15 | 2012 | 15521 | 0.340 |
Why?
|
Coronary Disease | 7 | 2012 | 5921 | 0.330 |
Why?
|
Soot | 1 | 2011 | 221 | 0.330 |
Why?
|
Weather | 4 | 2011 | 231 | 0.330 |
Why?
|
Temperature | 7 | 2011 | 2219 | 0.320 |
Why?
|
Genome-Wide Association Study | 23 | 2012 | 12676 | 0.310 |
Why?
|
Heart Conduction System | 2 | 2012 | 1008 | 0.310 |
Why?
|
Regression Analysis | 13 | 2011 | 6345 | 0.290 |
Why?
|
Cities | 6 | 2011 | 541 | 0.290 |
Why?
|
von Willebrand Factor | 3 | 2010 | 677 | 0.290 |
Why?
|
Aged | 74 | 2012 | 169292 | 0.270 |
Why?
|
Long QT Syndrome | 2 | 2011 | 466 | 0.270 |
Why?
|
Disease | 1 | 2011 | 670 | 0.260 |
Why?
|
Leukocyte Count | 1 | 2010 | 1597 | 0.260 |
Why?
|
Physical Exertion | 1 | 2008 | 668 | 0.250 |
Why?
|
Electrocardiography | 10 | 2012 | 6387 | 0.240 |
Why?
|
Aerosols | 5 | 2011 | 635 | 0.240 |
Why?
|
Poisson Distribution | 5 | 2011 | 504 | 0.240 |
Why?
|
Haplotypes | 10 | 2012 | 2715 | 0.230 |
Why?
|
Middle Aged | 73 | 2012 | 220858 | 0.230 |
Why?
|
Tachycardia, Supraventricular | 1 | 2006 | 273 | 0.230 |
Why?
|
Coronary Artery Disease | 5 | 2011 | 6506 | 0.220 |
Why?
|
Blood Coagulation | 4 | 2011 | 1156 | 0.220 |
Why?
|
Dyspnea | 1 | 2011 | 1347 | 0.210 |
Why?
|
Carbon Monoxide | 5 | 2010 | 547 | 0.210 |
Why?
|
Motor Vehicles | 1 | 2004 | 282 | 0.210 |
Why?
|
Nitrogen Dioxide | 6 | 2011 | 521 | 0.200 |
Why?
|
Public Health | 4 | 2011 | 2672 | 0.200 |
Why?
|
Heart Diseases | 5 | 2011 | 2795 | 0.200 |
Why?
|
Hazardous Substances | 1 | 2002 | 153 | 0.190 |
Why?
|
Respiration Disorders | 1 | 2005 | 366 | 0.190 |
Why?
|
Male | 78 | 2012 | 360703 | 0.190 |
Why?
|
Cross-Over Studies | 4 | 2011 | 2082 | 0.190 |
Why?
|
Humans | 110 | 2012 | 761222 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2012 | 12159 | 0.170 |
Why?
|
Risk Assessment | 14 | 2011 | 24022 | 0.170 |
Why?
|
Multigene Family | 4 | 2011 | 1075 | 0.170 |
Why?
|
Nanoparticles | 1 | 2011 | 1959 | 0.170 |
Why?
|
Thromboplastin | 2 | 2011 | 286 | 0.160 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2011 | 127 | 0.160 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2011 | 3201 | 0.150 |
Why?
|
Meteorological Concepts | 2 | 2009 | 30 | 0.150 |
Why?
|
Genetic Loci | 4 | 2011 | 2623 | 0.150 |
Why?
|
Tachycardia, Ventricular | 1 | 2006 | 1305 | 0.150 |
Why?
|
Genotype | 11 | 2012 | 12985 | 0.140 |
Why?
|
Prediabetic State | 3 | 2012 | 546 | 0.140 |
Why?
|
Chromosome Mapping | 5 | 2012 | 4612 | 0.140 |
Why?
|
Female | 68 | 2012 | 392552 | 0.140 |
Why?
|
Adult | 48 | 2012 | 221120 | 0.140 |
Why?
|
Sulfur Dioxide | 4 | 2011 | 178 | 0.130 |
Why?
|
Interleukin-1 | 2 | 2010 | 1250 | 0.130 |
Why?
|
Dust | 2 | 2010 | 486 | 0.120 |
Why?
|
Epidemiologic Studies | 3 | 2011 | 677 | 0.120 |
Why?
|
Gene Frequency | 6 | 2012 | 3603 | 0.120 |
Why?
|
Risk Factors | 25 | 2012 | 74241 | 0.120 |
Why?
|
Metabolome | 2 | 2011 | 989 | 0.120 |
Why?
|
Longitudinal Studies | 9 | 2011 | 14610 | 0.110 |
Why?
|
Time Factors | 11 | 2011 | 39957 | 0.110 |
Why?
|
Chromosomes, Human, Pair 1 | 3 | 2011 | 638 | 0.110 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2011 | 1241 | 0.110 |
Why?
|
Comorbidity | 7 | 2012 | 10516 | 0.110 |
Why?
|
Inflammation | 7 | 2011 | 10759 | 0.110 |
Why?
|
Sickness Impact Profile | 2 | 2011 | 299 | 0.110 |
Why?
|
Aged, 80 and over | 21 | 2012 | 58952 | 0.110 |
Why?
|
China | 4 | 2011 | 2374 | 0.110 |
Why?
|
Europe | 6 | 2009 | 3423 | 0.100 |
Why?
|
Leisure Activities | 2 | 2011 | 308 | 0.100 |
Why?
|
Quantitative Trait Loci | 2 | 2012 | 2113 | 0.100 |
Why?
|
Case-Control Studies | 10 | 2012 | 22174 | 0.100 |
Why?
|
Eukaryotic Initiation Factor-4G | 1 | 2012 | 67 | 0.100 |
Why?
|
Death Certificates | 2 | 2010 | 168 | 0.100 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2010 | 299 | 0.100 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2011 | 425 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 11 | 2012 | 17897 | 0.090 |
Why?
|
Fasting | 3 | 2012 | 1603 | 0.090 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2011 | 577 | 0.090 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2011 | 141 | 0.090 |
Why?
|
Logistic Models | 5 | 2011 | 13249 | 0.090 |
Why?
|
Cohort Studies | 18 | 2012 | 41496 | 0.090 |
Why?
|
Motor Activity | 2 | 2011 | 2712 | 0.090 |
Why?
|
Triterpenes | 1 | 2011 | 76 | 0.090 |
Why?
|
Atmosphere | 1 | 2010 | 32 | 0.090 |
Why?
|
Overweight | 2 | 2012 | 2418 | 0.090 |
Why?
|
Torsades de Pointes | 1 | 2011 | 77 | 0.090 |
Why?
|
Serum Amyloid A Protein | 1 | 2010 | 126 | 0.090 |
Why?
|
Factor V | 1 | 2011 | 168 | 0.090 |
Why?
|
Blood Chemical Analysis | 1 | 2012 | 436 | 0.090 |
Why?
|
Exercise Test | 3 | 2008 | 2165 | 0.090 |
Why?
|
Lung Diseases | 2 | 2011 | 1910 | 0.090 |
Why?
|
Cause of Death | 2 | 2011 | 3688 | 0.090 |
Why?
|
Serum | 1 | 2011 | 208 | 0.090 |
Why?
|
Sensitivity and Specificity | 3 | 2011 | 14675 | 0.090 |
Why?
|
Geography | 2 | 2011 | 652 | 0.090 |
Why?
|
Odds Ratio | 4 | 2012 | 9652 | 0.080 |
Why?
|
Atrial Natriuretic Factor | 1 | 2011 | 350 | 0.080 |
Why?
|
Blood Pressure | 4 | 2011 | 8479 | 0.080 |
Why?
|
Factor VII | 1 | 2010 | 139 | 0.080 |
Why?
|
Oxidants, Photochemical | 1 | 2010 | 76 | 0.080 |
Why?
|
Duffy Blood-Group System | 1 | 2009 | 58 | 0.080 |
Why?
|
Climate | 1 | 2010 | 147 | 0.080 |
Why?
|
Chloride Channels | 1 | 2011 | 221 | 0.080 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2011 | 276 | 0.080 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2010 | 410 | 0.080 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2010 | 375 | 0.080 |
Why?
|
Promoter Regions, Genetic | 3 | 2009 | 5773 | 0.080 |
Why?
|
Sex Characteristics | 2 | 2011 | 2640 | 0.080 |
Why?
|
Genetic Variation | 5 | 2012 | 6567 | 0.080 |
Why?
|
Blood Glucose | 3 | 2012 | 6392 | 0.080 |
Why?
|
Arm | 1 | 2012 | 589 | 0.080 |
Why?
|
Epidemiology | 1 | 2011 | 280 | 0.080 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11855 | 0.080 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2010 | 1128 | 0.080 |
Why?
|
Prospective Studies | 11 | 2012 | 54437 | 0.080 |
Why?
|
Menarche | 1 | 2011 | 532 | 0.080 |
Why?
|
Amidohydrolases | 1 | 2009 | 158 | 0.080 |
Why?
|
Vesicular Transport Proteins | 1 | 2011 | 374 | 0.080 |
Why?
|
Polymorphism, Genetic | 2 | 2009 | 4243 | 0.080 |
Why?
|
Arachidonate 15-Lipoxygenase | 1 | 2008 | 84 | 0.080 |
Why?
|
Wind | 1 | 2008 | 42 | 0.080 |
Why?
|
Lipoproteins, LDL | 1 | 2011 | 643 | 0.080 |
Why?
|
Peroxidase | 1 | 2011 | 610 | 0.080 |
Why?
|
Sphingolipids | 1 | 2009 | 173 | 0.070 |
Why?
|
Hypertension | 5 | 2012 | 8536 | 0.070 |
Why?
|
Plasma | 1 | 2011 | 586 | 0.070 |
Why?
|
Metabolic Networks and Pathways | 1 | 2012 | 790 | 0.070 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2009 | 322 | 0.070 |
Why?
|
Factor VIII | 1 | 2010 | 349 | 0.070 |
Why?
|
Parkinson Disease | 2 | 2012 | 2867 | 0.070 |
Why?
|
Lymphocyte Count | 1 | 2010 | 781 | 0.070 |
Why?
|
Body Mass Index | 8 | 2012 | 12952 | 0.070 |
Why?
|
Cold Temperature | 1 | 2011 | 783 | 0.070 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2011 | 774 | 0.070 |
Why?
|
P-Selectin | 1 | 2010 | 599 | 0.070 |
Why?
|
ABO Blood-Group System | 1 | 2010 | 381 | 0.070 |
Why?
|
Chemokine CCL2 | 1 | 2009 | 602 | 0.070 |
Why?
|
Homozygote | 2 | 2009 | 1775 | 0.070 |
Why?
|
Periodicity | 1 | 2008 | 347 | 0.070 |
Why?
|
Registries | 5 | 2011 | 8246 | 0.070 |
Why?
|
Lipoproteins | 1 | 2011 | 877 | 0.070 |
Why?
|
Chromosomes, Human | 1 | 2008 | 442 | 0.070 |
Why?
|
Environmental Health | 1 | 2009 | 289 | 0.070 |
Why?
|
Nitrous Oxide | 1 | 2006 | 166 | 0.060 |
Why?
|
Metabolomics | 2 | 2012 | 1658 | 0.060 |
Why?
|
Corneal Diseases | 1 | 2011 | 539 | 0.060 |
Why?
|
Oxidative Stress | 3 | 2011 | 3114 | 0.060 |
Why?
|
Quality Control | 1 | 2008 | 833 | 0.060 |
Why?
|
Cataract | 1 | 2011 | 828 | 0.060 |
Why?
|
Rest | 1 | 2010 | 920 | 0.060 |
Why?
|
American Heart Association | 1 | 2010 | 1043 | 0.060 |
Why?
|
Carbon | 2 | 2008 | 665 | 0.060 |
Why?
|
Retinal Diseases | 1 | 2011 | 705 | 0.060 |
Why?
|
Antigen Presentation | 1 | 2010 | 1251 | 0.060 |
Why?
|
Respiratory Function Tests | 1 | 2010 | 1685 | 0.060 |
Why?
|
Phenotype | 6 | 2012 | 16575 | 0.060 |
Why?
|
Spectrum Analysis | 1 | 2006 | 449 | 0.060 |
Why?
|
Hot Temperature | 1 | 2011 | 1434 | 0.060 |
Why?
|
Cerebrovascular Disorders | 1 | 2011 | 1474 | 0.060 |
Why?
|
Endothelium, Vascular | 2 | 2008 | 4420 | 0.060 |
Why?
|
Genetic Markers | 4 | 2012 | 2599 | 0.060 |
Why?
|
Netherlands | 3 | 2005 | 2222 | 0.060 |
Why?
|
DNA | 2 | 2008 | 7189 | 0.060 |
Why?
|
Glucose Tolerance Test | 3 | 2012 | 1178 | 0.060 |
Why?
|
Body Height | 1 | 2010 | 1566 | 0.060 |
Why?
|
Chest Pain | 1 | 2011 | 1097 | 0.060 |
Why?
|
Tobacco Smoke Pollution | 1 | 2010 | 821 | 0.060 |
Why?
|
Death, Sudden, Cardiac | 1 | 2012 | 1560 | 0.060 |
Why?
|
Fatigue | 1 | 2011 | 1550 | 0.060 |
Why?
|
Rabbits | 1 | 2010 | 4750 | 0.050 |
Why?
|
Linear Models | 2 | 2011 | 5869 | 0.050 |
Why?
|
Body Composition | 1 | 2012 | 2427 | 0.050 |
Why?
|
Time | 1 | 2004 | 545 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2008 | 2928 | 0.050 |
Why?
|
Geriatric Assessment | 1 | 2010 | 1409 | 0.050 |
Why?
|
Cost of Illness | 1 | 2012 | 1936 | 0.050 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2011 | 1725 | 0.050 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2005 | 268 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2011 | 2567 | 0.050 |
Why?
|
Homeostasis | 2 | 2010 | 3322 | 0.050 |
Why?
|
Atrial Fibrillation | 2 | 2010 | 5114 | 0.050 |
Why?
|
Glaucoma | 1 | 2011 | 1186 | 0.050 |
Why?
|
Quality of Life | 3 | 2012 | 13367 | 0.050 |
Why?
|
Inflammation Mediators | 2 | 2009 | 1885 | 0.050 |
Why?
|
Lung | 3 | 2011 | 9979 | 0.050 |
Why?
|
Blood Platelets | 2 | 2010 | 2477 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2019 | 0.050 |
Why?
|
Monocytes | 1 | 2010 | 2570 | 0.050 |
Why?
|
Myocardium | 2 | 2011 | 4746 | 0.050 |
Why?
|
Nitric Oxide | 2 | 2008 | 2137 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2008 | 1265 | 0.050 |
Why?
|
Sex Factors | 4 | 2011 | 10553 | 0.050 |
Why?
|
Population | 2 | 2012 | 141 | 0.050 |
Why?
|
Models, Genetic | 4 | 2012 | 3430 | 0.050 |
Why?
|
Urban Population | 1 | 2009 | 2036 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2009 | 2802 | 0.040 |
Why?
|
Autonomic Nervous System | 1 | 2005 | 704 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2012 | 3313 | 0.040 |
Why?
|
Heart | 2 | 2010 | 4431 | 0.040 |
Why?
|
Activities of Daily Living | 2 | 2010 | 2420 | 0.040 |
Why?
|
Genome, Human | 2 | 2010 | 4423 | 0.040 |
Why?
|
Social Class | 1 | 2009 | 1993 | 0.040 |
Why?
|
Body Weight | 1 | 2010 | 4618 | 0.040 |
Why?
|
Models, Statistical | 3 | 2009 | 5081 | 0.040 |
Why?
|
Life Style | 1 | 2011 | 3907 | 0.040 |
Why?
|
Age Factors | 4 | 2012 | 18384 | 0.040 |
Why?
|
Finland | 3 | 2005 | 607 | 0.040 |
Why?
|
Health Care Costs | 1 | 2011 | 3239 | 0.040 |
Why?
|
Pedigree | 3 | 2011 | 4537 | 0.040 |
Why?
|
Models, Biological | 3 | 2012 | 9458 | 0.040 |
Why?
|
Vitamin D | 1 | 2011 | 3301 | 0.040 |
Why?
|
Glucose | 1 | 2009 | 4342 | 0.040 |
Why?
|
Markov Chains | 2 | 2011 | 965 | 0.040 |
Why?
|
Diabetes Mellitus | 3 | 2012 | 5842 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2004 | 1791 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 3803 | 0.030 |
Why?
|
Likelihood Functions | 2 | 2011 | 991 | 0.030 |
Why?
|
Chronic Disease | 1 | 2011 | 9319 | 0.030 |
Why?
|
Smoking | 2 | 2010 | 9055 | 0.030 |
Why?
|
Life Expectancy | 1 | 2002 | 1242 | 0.030 |
Why?
|
Mental Health | 1 | 2010 | 3251 | 0.030 |
Why?
|
Self Report | 3 | 2011 | 3727 | 0.030 |
Why?
|
Humidity | 2 | 2009 | 205 | 0.030 |
Why?
|
Reproducibility of Results | 5 | 2012 | 20118 | 0.030 |
Why?
|
Meta-Analysis as Topic | 2 | 2010 | 1381 | 0.030 |
Why?
|
Alleles | 3 | 2011 | 6857 | 0.030 |
Why?
|
Obesity | 3 | 2012 | 12940 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2011 | 3407 | 0.030 |
Why?
|
Hospitalization | 2 | 2011 | 10707 | 0.030 |
Why?
|
Exercise | 1 | 2010 | 5874 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2011 | 5333 | 0.030 |
Why?
|
Health Status Indicators | 2 | 2009 | 970 | 0.030 |
Why?
|
Ozone | 2 | 2008 | 482 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2008 | 7804 | 0.030 |
Why?
|
Animals | 6 | 2012 | 168089 | 0.030 |
Why?
|
trans-Golgi Network | 1 | 2011 | 33 | 0.020 |
Why?
|
Erythrocytes | 2 | 2012 | 2413 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2012 | 659 | 0.020 |
Why?
|
Patient Readmission | 1 | 2005 | 3265 | 0.020 |
Why?
|
Aging | 1 | 2010 | 8702 | 0.020 |
Why?
|
Hydrogen Bonding | 1 | 2011 | 289 | 0.020 |
Why?
|
Rats, Inbred SHR | 1 | 2010 | 186 | 0.020 |
Why?
|
Health Surveys | 2 | 2012 | 4037 | 0.020 |
Why?
|
Acute-Phase Reaction | 1 | 2010 | 91 | 0.020 |
Why?
|
Population Groups | 1 | 2011 | 207 | 0.020 |
Why?
|
Base Pairing | 1 | 2010 | 139 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2012 | 39127 | 0.020 |
Why?
|
Carnitine | 1 | 2011 | 252 | 0.020 |
Why?
|
Cross-Sectional Studies | 4 | 2012 | 26072 | 0.020 |
Why?
|
Injections, Spinal | 1 | 2010 | 317 | 0.020 |
Why?
|
Prevalence | 3 | 2012 | 15721 | 0.020 |
Why?
|
Work | 1 | 2010 | 195 | 0.020 |
Why?
|
Interleukin-1alpha | 1 | 2009 | 86 | 0.020 |
Why?
|
Young Adult | 6 | 2011 | 59222 | 0.020 |
Why?
|
Air | 1 | 2009 | 187 | 0.020 |
Why?
|
Glutathione Transferase | 1 | 2010 | 564 | 0.020 |
Why?
|
Data Collection | 2 | 2011 | 3320 | 0.020 |
Why?
|
Receptors, Interleukin-1 | 1 | 2009 | 262 | 0.020 |
Why?
|
Endosomes | 1 | 2011 | 518 | 0.020 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2010 | 241 | 0.020 |
Why?
|
Diabetic Neuropathies | 1 | 2012 | 406 | 0.020 |
Why?
|
Thrombin | 1 | 2011 | 593 | 0.020 |
Why?
|
Risk | 2 | 2010 | 9616 | 0.020 |
Why?
|
Vital Capacity | 1 | 2011 | 970 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2011 | 590 | 0.020 |
Why?
|
Glycine | 1 | 2011 | 659 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2009 | 174 | 0.020 |
Why?
|
Spirometry | 1 | 2011 | 928 | 0.020 |
Why?
|
North Carolina | 1 | 2008 | 324 | 0.020 |
Why?
|
Body Size | 1 | 2010 | 463 | 0.020 |
Why?
|
Health Status | 2 | 2011 | 4077 | 0.020 |
Why?
|
Soil | 1 | 2008 | 116 | 0.020 |
Why?
|
Potassium | 1 | 2011 | 1309 | 0.020 |
Why?
|
Office Visits | 1 | 2011 | 593 | 0.020 |
Why?
|
Fluorescence | 1 | 2010 | 751 | 0.020 |
Why?
|
Anthropometry | 1 | 2012 | 1338 | 0.020 |
Why?
|
Blood Pressure Determination | 1 | 2011 | 633 | 0.020 |
Why?
|
Hemostasis | 1 | 2010 | 470 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1737 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2010 | 965 | 0.020 |
Why?
|
Sulfates | 1 | 2008 | 378 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1636 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2012 | 2340 | 0.020 |
Why?
|
Cell Size | 1 | 2008 | 625 | 0.020 |
Why?
|
Genetics, Population | 1 | 2011 | 935 | 0.020 |
Why?
|
Blood Proteins | 1 | 2012 | 1173 | 0.020 |
Why?
|
Protein Precursors | 1 | 2011 | 1132 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2011 | 12474 | 0.020 |
Why?
|
Organic Chemicals | 1 | 2007 | 210 | 0.020 |
Why?
|
Exons | 1 | 2012 | 2380 | 0.020 |
Why?
|
Eye Diseases | 1 | 2012 | 653 | 0.020 |
Why?
|
Waist Circumference | 1 | 2010 | 933 | 0.020 |
Why?
|
Hormones | 1 | 2010 | 868 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2011 | 1813 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2011 | 1256 | 0.020 |
Why?
|
Age Distribution | 1 | 2011 | 2871 | 0.020 |
Why?
|
Drug Utilization | 1 | 2011 | 1188 | 0.020 |
Why?
|
Thrombosis | 2 | 2010 | 2944 | 0.020 |
Why?
|
History, 18th Century | 1 | 2005 | 206 | 0.020 |
Why?
|
Amino Acids | 1 | 2011 | 1703 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 3418 | 0.020 |
Why?
|
Neoplasms | 2 | 2011 | 22142 | 0.020 |
Why?
|
International Normalized Ratio | 1 | 2006 | 382 | 0.010 |
Why?
|
E-Selectin | 1 | 2006 | 577 | 0.010 |
Why?
|
Age of Onset | 1 | 2011 | 3307 | 0.010 |
Why?
|
Employment | 1 | 2010 | 1114 | 0.010 |
Why?
|
Macrophages | 2 | 2009 | 5755 | 0.010 |
Why?
|
Educational Status | 1 | 2011 | 2510 | 0.010 |
Why?
|
Reference Values | 1 | 2011 | 4921 | 0.010 |
Why?
|
Interleukin-1beta | 1 | 2009 | 1002 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2008 | 1994 | 0.010 |
Why?
|
ras Proteins | 1 | 2009 | 1055 | 0.010 |
Why?
|
Protein Conformation | 1 | 2011 | 3933 | 0.010 |
Why?
|
Drug Costs | 1 | 2011 | 1183 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2011 | 1893 | 0.010 |
Why?
|
United States Environmental Protection Agency | 1 | 2003 | 139 | 0.010 |
Why?
|
United States | 3 | 2010 | 72341 | 0.010 |
Why?
|
Longevity | 1 | 2010 | 1063 | 0.010 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 898 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2012 | 6011 | 0.010 |
Why?
|
Heterozygote | 1 | 2008 | 2778 | 0.010 |
Why?
|
Cardiovascular System | 1 | 2009 | 836 | 0.010 |
Why?
|
Angina Pectoris | 1 | 2005 | 959 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4111 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2011 | 3770 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2009 | 2138 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2011 | 2770 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3331 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4009 | 0.010 |
Why?
|
Social Support | 1 | 2010 | 2175 | 0.010 |
Why?
|
Population Surveillance | 1 | 2010 | 2598 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17598 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3691 | 0.010 |
Why?
|
Research Support as Topic | 1 | 2003 | 697 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2691 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2010 | 4340 | 0.010 |
Why?
|
Adolescent | 3 | 2012 | 88300 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2009 | 2131 | 0.010 |
Why?
|
Neutrophils | 1 | 2010 | 3763 | 0.010 |
Why?
|
Software | 1 | 2012 | 4431 | 0.010 |
Why?
|
Genetic Testing | 1 | 2011 | 3537 | 0.010 |
Why?
|
Insulin | 1 | 2012 | 6588 | 0.010 |
Why?
|
Proteins | 1 | 2012 | 5993 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2010 | 3952 | 0.010 |
Why?
|
Biomedical Research | 1 | 2011 | 3434 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 6180 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15308 | 0.010 |
Why?
|
Research | 1 | 2003 | 1976 | 0.010 |
Why?
|
Rats | 1 | 2010 | 23705 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2011 | 15841 | 0.010 |
Why?
|
Databases, Factual | 1 | 2008 | 7965 | 0.010 |
Why?
|
Mental Disorders | 1 | 2012 | 6823 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10756 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2010 | 7865 | 0.010 |
Why?
|
Stroke | 1 | 2012 | 9721 | 0.010 |
Why?
|
Mutation | 1 | 2012 | 30004 | 0.000 |
Why?
|
Mice | 1 | 2012 | 81330 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2011 | 64681 | 0.000 |
Why?
|